Buck Wealth Strategies, LLC Novo Nordisk A S Transaction History

Buck Wealth Strategies, LLC

  • $317 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$122.71 - $146.91 $293,645 - $351,555
2,393 New
2,393 $341,000
Q4 2023

Jan 23, 2024
BUY
$87.78 - $105.45 $82,425 - $99,017
939 Added 78.51%
2,135 $220,000
Q3 2023

Nov 06, 2023
BUY
$90.94 - $199.54 $54,382 - $119,324
598 Added 100.0%
1,196 $108,000
Q2 2023

Nov 06, 2023
BUY
$155.98 - $172.65 $779 - $863
5 Added 0.84%
598 $96.8 Million
Q1 2023

Nov 06, 2023
BUY
$132.34 - $159.14 $78,477 - $94,370
593 New
593 $94.4 Million

Others Institutions Holding NVO

# of Institutions
1,950
Shares Held
319M
Call Options Held
5.22M
Put Options Held
5M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $246B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Buck Wealth Strategies, LLC Portfolio

Follow Buck Wealth Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buck Wealth Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Buck Wealth Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email